SG11201708181RA - Methods for the treatment of inflammatory disorders - Google Patents
Methods for the treatment of inflammatory disordersInfo
- Publication number
- SG11201708181RA SG11201708181RA SG11201708181RA SG11201708181RA SG11201708181RA SG 11201708181R A SG11201708181R A SG 11201708181RA SG 11201708181R A SG11201708181R A SG 11201708181RA SG 11201708181R A SG11201708181R A SG 11201708181RA SG 11201708181R A SG11201708181R A SG 11201708181RA
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- methods
- inflammatory disorders
- disorders
- inflammatory
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1506229.2A GB201506229D0 (en) | 2015-04-13 | 2015-04-13 | Methods For the Treatment Of Inflammatory Disorders |
| GBGB1506419.9A GB201506419D0 (en) | 2015-04-15 | 2015-04-15 | Methods for the treatment of inflammatory disorders |
| GBGB1507113.7A GB201507113D0 (en) | 2015-04-27 | 2015-04-27 | Methods for the treatment of inflammatory disorders |
| GBGB1513345.7A GB201513345D0 (en) | 2015-07-29 | 2015-07-29 | Methods for the treatment of Inflammatory disorders |
| GBGB1513993.4A GB201513993D0 (en) | 2015-08-07 | 2015-08-07 | Methods for the treatment of inflammatory disorders |
| GBGB1521543.7A GB201521543D0 (en) | 2015-12-07 | 2015-12-07 | Methods for the treatment of inflammatory disorders |
| PCT/EP2016/057104 WO2016165953A1 (en) | 2015-04-13 | 2016-03-31 | Methods for the treatment of inflammatory disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201708181RA true SG11201708181RA (en) | 2017-11-29 |
Family
ID=55650412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201708181RA SG11201708181RA (en) | 2015-04-13 | 2016-03-31 | Methods for the treatment of inflammatory disorders |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20180200257A1 (es) |
| EP (1) | EP3283078A1 (es) |
| JP (1) | JP2018511620A (es) |
| KR (1) | KR20170134750A (es) |
| CN (1) | CN107531694A (es) |
| AU (1) | AU2016248728A1 (es) |
| BR (1) | BR112017021583A2 (es) |
| CA (1) | CA2982630A1 (es) |
| EA (1) | EA201792264A1 (es) |
| MX (1) | MX2017013099A (es) |
| SG (1) | SG11201708181RA (es) |
| WO (1) | WO2016165953A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3043396A1 (en) | 2016-11-10 | 2018-05-17 | Galapagos Nv | Compounds and pharmaceutical compositions thereof for the treatment of inflammatory diseases |
| CN109111575B (zh) * | 2018-05-23 | 2021-03-23 | 中山大学 | 一种金属-有机框架纳米颗粒的制备方法和应用 |
| GB201808575D0 (en) * | 2018-05-24 | 2018-07-11 | Galapagos Nv | Methods for the treatment of psoriatic arthrits |
| WO2021168375A1 (en) * | 2020-02-20 | 2021-08-26 | Kite Pharma, Inc. | Chimeric antigen receptor t cell therapy |
| WO2022087313A1 (en) * | 2020-10-22 | 2022-04-28 | Progenity, Inc. | Methods of treating and predicting non-response to anti-tnf treatment in subjects with gastrointestinal tract diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3041B1 (ar) * | 2008-07-25 | 2016-09-05 | Galapagos Nv | مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية |
| TWI462920B (zh) * | 2009-06-26 | 2014-12-01 | 葛萊伯格有限公司 | 用於治療退化性及發炎疾病之新穎化合物 |
| SI2863950T1 (sl) | 2012-06-22 | 2018-10-30 | Galapagos Nv | Aminotriazolopiridin za uporabo pri zdravljenju vnetja in njegovi farmacevtski sestavki |
| GB201402071D0 (en) * | 2014-02-07 | 2014-03-26 | Galapagos Nv | Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
-
2016
- 2016-03-31 WO PCT/EP2016/057104 patent/WO2016165953A1/en active Application Filing
- 2016-03-31 AU AU2016248728A patent/AU2016248728A1/en not_active Abandoned
- 2016-03-31 EP EP16713879.1A patent/EP3283078A1/en not_active Withdrawn
- 2016-03-31 JP JP2017553342A patent/JP2018511620A/ja active Pending
- 2016-03-31 MX MX2017013099A patent/MX2017013099A/es unknown
- 2016-03-31 BR BR112017021583A patent/BR112017021583A2/pt not_active Application Discontinuation
- 2016-03-31 SG SG11201708181RA patent/SG11201708181RA/en unknown
- 2016-03-31 US US15/566,039 patent/US20180200257A1/en not_active Abandoned
- 2016-03-31 CA CA2982630A patent/CA2982630A1/en not_active Abandoned
- 2016-03-31 EA EA201792264A patent/EA201792264A1/ru unknown
- 2016-03-31 CN CN201680021850.7A patent/CN107531694A/zh active Pending
- 2016-03-31 KR KR1020177032856A patent/KR20170134750A/ko unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016248728A1 (en) | 2017-10-12 |
| CA2982630A1 (en) | 2016-10-20 |
| CN107531694A (zh) | 2018-01-02 |
| WO2016165953A1 (en) | 2016-10-20 |
| EP3283078A1 (en) | 2018-02-21 |
| BR112017021583A2 (pt) | 2018-07-03 |
| JP2018511620A (ja) | 2018-04-26 |
| US20180200257A1 (en) | 2018-07-19 |
| KR20170134750A (ko) | 2017-12-06 |
| EA201792264A1 (ru) | 2018-04-30 |
| MX2017013099A (es) | 2018-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285151A (en) | Methods for the treatment of fgf21-related disorders | |
| IL273693A (en) | Treatment of inflammatory disorders | |
| EP3340982A4 (en) | COMPOUNDS FOR THE TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | |
| IL279308A (en) | Methods for the treatment of heptidine-mediated disorders | |
| GB201402070D0 (en) | Pharmaceutical compositions for the treatment of inflammatory disorders | |
| IL253118A0 (en) | Methods for treating inflammatory diseases | |
| HK1252996A1 (zh) | 用於治療癲癇的方法 | |
| HK1252037A1 (zh) | 治療炎性疾病的方法 | |
| SG10202012106WA (en) | Methods for treating inflammatory conditions of the lungs | |
| SG11201708181RA (en) | Methods for the treatment of inflammatory disorders | |
| HK1221166A1 (zh) | 炎症性病症的治療 | |
| HK1247558A1 (zh) | 塞內可瑞偉洛克(cenicriviroc)用於治療纖維化 | |
| GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
| EP3215178A4 (en) | Treatment of cns inflammatory disorders | |
| HK1250624A1 (zh) | 用於治療心血管障礙的方法 | |
| GB201521543D0 (en) | Methods for the treatment of inflammatory disorders | |
| GB201513993D0 (en) | Methods for the treatment of inflammatory disorders | |
| GB201513345D0 (en) | Methods for the treatment of Inflammatory disorders | |
| GB201507113D0 (en) | Methods for the treatment of inflammatory disorders | |
| GB201506419D0 (en) | Methods for the treatment of inflammatory disorders | |
| GB201506229D0 (en) | Methods For the Treatment Of Inflammatory Disorders | |
| PT3420084T (pt) | Nova abordagem para tratamento de disfunções inflamatórias | |
| GB201516418D0 (en) | Treatment of acute inflammatory disorders | |
| GB201516140D0 (en) | Treatment of acute inflammatory disorders | |
| GB201521542D0 (en) | Methods for the treatment of cardiovascular disorders |